BioHarvest Sciences Inc. Common Stock (BHST) — Cash Flow-to-Debt Ratio
BioHarvest Sciences Inc. Common Stock (BHST) has a Cash Flow-to-Debt Ratio of -0.07x as of March 2026, meaning its operating cash flow of $-1.58 Million could theoretically repay 0% of its total liabilities ($22.54 Million) in one year. See working capital to net assets of BioHarvest Sciences Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioHarvest Sciences Inc. Common Stock Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for BioHarvest Sciences Inc. Common Stock across 7 annual periods. Also explore BioHarvest Sciences Inc. Common Stock (BHST) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BioHarvest Sciences Inc. Common Stock (2019–2025)
Year-by-year debt coverage analysis for BioHarvest Sciences Inc. Common Stock. For market capitalisation and broader financial context, see how much is BioHarvest Sciences Inc. Common Stock worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.33x | $-7.23 Million | $22.22 Million | ▼ -15.2% |
| 2024 | -0.28x | $-6.68 Million | $23.67 Million | ▲ +1.1% |
| 2023 | -0.29x | $-8.52 Million | $29.86 Million | ▲ +52.7% |
| 2022 | -0.60x | $-9.24 Million | $15.32 Million | ▲ +34.7% |
| 2021 | -0.92x | $-6.79 Million | $7.35 Million | ▼ -81.2% |
| 2020 | -0.51x | $-3.88 Million | $7.60 Million | ▼ -520.4% |
| 2019 | -0.08x | $-2.38 Million | $28.99 Million | — |